Latest News
-
Bevacizumab, Dexamethosone Evaluated for CRVO
Data from 2 new studies are contributing to the evolution in retinal vein occlusion treatment that first began several years ago. The resear…
from EyewireToday.com
-
ThromboGenics Receives Notice from FDA of Advisory Committee Meeting for Ocriplasmin
ThromboGenics NV announced that the US Food and Drug Administration has notified the company that its new biologic license application for o…
from EyewireToday.com
-
Alimera Sciences' Iluvien Receives Marketing Authorization in Portugal for the Treatment o…
Alimera Sciences, Inc., announced the National Authority of Medicines and Health Products (Autoridade Nacional do Medicamento e Produtos de …
from EyewireToday.com
-
Treating Central Serous Retinopathy: Adjunctive Nutritional Management
Central serous retinopathy (CSR), or central serous chorioretinopathy (CSC), is an eye disease that causes visual impairment. The condition …
from EyewireToday.com
-
Untreated Sleep Apnea Interferes with Treatment for AMD
Patients with age-related macular degeneration (AMD) who do not respond to treatment with intravitreal anti–vascular endothelial growth fa…
from EyewireToday.com
-
Advanced Cell Technology to Present at World Stem Cells and Regenerative Medicine Congress…
Advanced Cell Technology, Inc. announced that chairman and CEO Gary Rabin will be presenting at the World Stem Cells and Regenerative Medici…
from EyewireToday.com
-
Simple Solution For Age Related Macular Degeneration
A device which could restore sight to patients with one of the most common causes of blindness in the developed world is under development i…
from EyewireToday.com
-
New Advances In Treating Inherited Retinal Diseases
Gene therapy strategies to prevent and treat inherited diseases of the retina that can cause blindness have progressed rapidly. Positive res…
from EyewireToday.com
-
FDA Grants Fast Track Designation to Ohr Pharmaceutical's Squalamine Eye Drops for the Tre…
Ohr Pharmaceutical, Inc., announced that its Squalamine Eye Drops, a potent inhibitor of multiple growth factors implicated in angiogenesis,…
from EyewireToday.com
-
New Type of Retinal Prosthesis Could Better Restore Sight to Blind, Stanford Study Says
Using tiny solar-panel-like cells surgically placed underneath the retina, scientists at the Stanford University School of Medicine have dev…
from EyewireToday.com
-
High-Dose Ranibizumab No Better Than Standard Dose for AMD
High-dose ranibizumab (Lucentis) does not provide better visual acuity than standard-dose ranibizumab in newly diagnosed wet age-related mac…
from EyewireToday.com
-
Topical Aganirsen Found To Be Active In Retinal Disease
Gene Signal, a company focused on developing innovative drugs to manage angiogenesis based conditions, has announced that positive data from…
from EyewireToday.com
-
Retinopathy Screenings Can Be Less Frequent
Screening for retinopathy every 2 years instead of the recommended annual screening would be safe and could reduce screening costs by about …
from EyewireToday.com
-
Retinal Microchip Restores Vision in Retinitis Pigmentosa
A subretinal microchip implant has entered new clinical trials in the United Kingdom and Hong Kong, and early results are encouraging, accor…
from EyewireToday.com
